SCHEMBL7007892

SCHEMBL7007892

CC(C)n1c(=O)n(C)c(=O)c2cc(Cc3nc4ccccc4n3C)sc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 5/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
KDR P35968 1/20 0.39
PTK2 Q05397 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
RECQL P46063 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 4/20 0.38
TSHR P16473 2/20 0.37
MEN1 O00255 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7007438 0.86 SLC16A1 (0.44) ALDH1A1LMNAMEN1KMT2A
SCHEMBL7008632 0.80 BRD4 (0.41) ALDH1A1LMNAKDRPTK2PIK3CD
SCHEMBL5864573 0.80 PDE3B (0.44) ALDH1A1LMNASMN1; SMN2NPC1KDM4E
SCHEMBL7006914 0.78 PDE2A (0.45) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL7013217 0.78 KMT2A (0.44) ALDH1A1LMNASMN1; SMN2KDRPTK2
SCHEMBL7007770 0.73 ADORA2B (0.35) ALDH1A1LMNA
SCHEMBL1059693 0.68 RAB9A (0.64) LMNASMN1; SMN2NPC1RAB9AHDAC6
SCHEMBL5864675 0.67 LMNA (0.44) ALDH1A1LMNASMN1; SMN2RECQLMAPT
SCHEMBL6808474 0.67 MAPK1 (0.49) ALDH1A1LMNASMN1; SMN2NPC1RAB9A
SCHEMBL7010147 0.66 ALDH1A1 (0.44) ALDH1A1LMNASMN1; SMN2TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1107973-B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY ASTRAZENECA AB (SE) 2003-11-05 EP claimed